Background
This study is going to evaluate the benefit and low morbidity rate of medial pedicle reduction mammoplasty on improving symptoms of macromastia with preservation of nipple and areola and avoiding depigmentation and hyperpigmentation of nipple and areola, preservation of lactation and about contour of the breast.
Objective
This study aim to evaluate the benefit and low morbidity rate of medial pedicle reduction mammoplasty on improving symptoms of macromastia with preservation of nipple and areola and avoiding depigmentation and hyperpigmentation of nipple and areola, preservation of lactation and about contour of the breast.
Patient and Methods
This is a clinical study including twenty female patients all had the problem of macromastia and all have undergone medial pedicle reduction mammoplasty at Benha university. Their mean age was 31years (25-45 years). All patients were evaluated preoperative and postoperative with mean follow up to 6months.
Results
Clinical outcome measures significantly improved after surgery. Preoperatively there were 20 patients suffering from macromastia. Postoperatively they were all satisfied with the results with only 2 patients suffered from complications 1 with wound dehiscence and 1 with nipple and areola necrosis. 4 patients had secondary surgery 2 of them had liposuction of lateral bulge, 1 patients had revision of scar and 1 patient had excision of dog ear.
Conclusion
. This study demonstrates that medial pedicle reduction mammoplasty is a safe surgical option for severe mammary hypertrophy. Current options include amputation mammoplasty with free-nipple graft and the inferior pedicle and bipedicle techniques.